These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 29649819

  • 1. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S, Brigo F, Cagnetti C, Di Napoli M, Silvestrini M.
    Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 4. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S, Russo F, Campana C, Agostoni E.
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P, Khalid MF, Khattak F, Bagai J, Bhogal S, Ladia V, Mukherjee D, Daggubati R, Paul TK.
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [Abstract] [Full Text] [Related]

  • 6. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK, Abdelgadir I, Boudjemline Y, Hijazi ZM.
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [Abstract] [Full Text] [Related]

  • 7. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F, Al-Khadra Y, Soud M, Fanari Z, Alraies MC.
    Cerebrovasc Dis; 2018 Jul; 45(3-4):162-169. PubMed ID: 29597192
    [Abstract] [Full Text] [Related]

  • 8. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.
    Cochrane Database Syst Rev; 2015 Sep 08; 2015(9):CD009938. PubMed ID: 26346232
    [Abstract] [Full Text] [Related]

  • 9. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM, Carroll JD.
    Circ Cardiovasc Interv; 2018 Mar 08; 11(3):e004152. PubMed ID: 29870380
    [Abstract] [Full Text] [Related]

  • 10. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.
    JACC Cardiovasc Interv; 2013 Dec 08; 6(12):1316-23. PubMed ID: 24139929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Tex Heart Inst J; 2014 Aug 08; 41(4):357-67. PubMed ID: 25120387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, DeLodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabrò RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Marco Bonifati D, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Tomelleri G, Spalloni A, Giorli E, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Piras V, Rasura M, Simone AM, Gamba M, Cerrato P, Zedde ML, Micieli G, Melis M, Massucco D, Guido D, De Giuli V, Bonaiti S, D'Amore C, La Starza S, Iacoviello L, Padovani A, Italian Project on Stroke in Young Adults (IPSYS) Investigators.
    Circ Cardiovasc Interv; 2016 Sep 08; 9(9):. PubMed ID: 27582111
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.
    Catheter Cardiovasc Interv; 2017 Jan 08; 89(1):124-133. PubMed ID: 27027873
    [Abstract] [Full Text] [Related]

  • 17. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Jun 08; 85(7):1262-7. PubMed ID: 24948394
    [Abstract] [Full Text] [Related]

  • 18. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A, Sławek S, Trojnarska O, Lesiak M, Grygier M.
    Catheter Cardiovasc Interv; 2018 Jul 08; 92(1):159-164. PubMed ID: 29068141
    [Abstract] [Full Text] [Related]

  • 19. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
    Udell JA, Opotowsky AR, Khairy P, Silversides CK, Gladstone DJ, O'Gara PT, Landzberg MJ.
    Can J Cardiol; 2014 Oct 08; 30(10):1216-24. PubMed ID: 25154803
    [Abstract] [Full Text] [Related]

  • 20. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
    Wang TKM, Wang MTM, Ruygrok P.
    Heart Lung Circ; 2019 Apr 08; 28(4):623-631. PubMed ID: 29602754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.